A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Obstructive sleep apnea occurs when the upper airway repeatedly collapses during sleep, temporarily blocking airflow ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

(Tim Kitchen/Getty Images) Sleeping with a clunky breathing machine is a problem for many with sleep apnea, but a more ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

A clinical trial suggests that a wake-promoting drug may help early-morning shift workers overcome the biological challenges ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...